MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.lfs.2025.124182

Медицинская библиотека · Life sciences · 2026

Risk stratification using inflammatory and metabolic biomarkers: A multi-cohort predictive study of mortality in atherosclerotic cardiovascular disease.

Li Xiao, Zeng Qingyue, Zhang Xiaoyu, Wang Shuangqiu, Jiang Tong, You Liangzheng, Shang Hongcai

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The pathological process of atherosclerotic cardiovascular disease (ASCVD) involves complex interactions between metabolic dysregulation and inflammatory responses. The stress hyperglycemia ratio (SHR) and neutrophil-to-lymphocyte ratio (NLR), as biomarkers reflecting metabolic stress and systemic inflammation respectively, have demonstrated significant value in ASCVD prognosis assessment. This study aims to investigate the predictive role of combined SHR and NLR indicators for all-cause mortality in ASCVD patients and their clinical applicability.

METHODS

ASCVD patients were identified from the Medical Information Mart for Intensive Care IV (MIMIC-IV) and National Health and Nutrition Examination Survey (NHANES) databases, stratified by SHR/NLR tertiles. Multivariable Cox regression, restricted cubic splines, time-dependent ROC, and machine learning models assessed mortality associations.

RESULTS

Among 6159 patients, the highest SHR tertile showed increased mortality (NHANES: HR = 1.20, 95 % CI 1.08-1.34; MIMIC-IV: HR = 2.27, 95 % CI 1.44-3.57). The highest NLR tertile showed elevated risk (NHANES: HR = 1.56, 95 % CI 1.39-1.74; MIMIC-IV: HR = 1.61, 95 % CI 1.03-2.52). The combined high SHR/NLR group exhibited the most pronounced risk (NHANES: HR = 1.54, 95 % CI 1.35-1.77; MIMIC-IV: HR = 2.90, 95 % CI 1.70-4.93), with significantly improved predictive accuracy.

CONCLUSION

The combined SHR-NLR assessment effectively quantifies combined metabolic-inflammatory injury and provides superior prognostic stratification for ASCVD patients compared to individual biomarker evaluation. These findings highlight the clinical potential of this dual-biomarker approach for enhancing risk prediction, though further prospective validation is warranted to establish its predictive utility across various patient populations.

Для цитирования: Li Xiao, Zeng Qingyue, Zhang Xiaoyu, Wang Shuangqiu, Jiang Tong, You Liangzheng, Shang Hongcai. Risk stratification using inflammatory and metabolic biomarkers: A multi-cohort predictive study of mortality in atherosclerotic cardiovascular disease.. Life sciences. 2026. DOI: 10.1016/j.lfs.2025.124182.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.